pharmatest.com
Pharmatest offers rat and rabbit osteoarthritis (OA) models for studying preclinical efficacy of disease and symptom modifying drug candidates, biosimilars and functional foods aimed at the treatment of OA.
http://www.pharmatest.com/en/services/skeletal-disease-models/osteoarthritis
Clinically predictive preclinical efficacy testing services at your disposal". Jussi Halleen - CEO, Pharmatest Services. In vitro assays, osteoclasts. In vitro assays, osteoblasts. Models of hormonal action. Pharmatest offers four rat models of OA, including:. MIA model, where OA is caused chemically by intra-articular injection of monoiodoacetate (MIA). MMT MCLT model, where OA is caused surgically by medial meniscal tear (MMT) and medial collateral ligament transection (MCLT). July 15, 2016. Pharmatest...
pharmatest.com
Pharmatest has carefully designed specific study setups for testing new drug candidates according to regulatory guidelines of FDA and EMEA.
http://www.pharmatest.com/company
Clinically predictive preclinical efficacy testing services at your disposal". Jussi Halleen - CEO, Pharmatest Services. Pharmatest's headquarters and preclinical research unit are located in Turku, Finland, where we operate in modern facilities including fully equipped research laboratories and barrier-type animal facilities. We have also sales offices located in Cambridge, MA, USA and Guangzhou, China. What can we do for You? July 15, 2016. Pharmatest Services Ltd (Pharmatest) has opened new US sales o...
pharmatest.com
SERVICES - Pharmatest Services
http://www.pharmatest.com/services
Clinically predictive preclinical efficacy testing services at your disposal". Jussi Halleen - CEO, Pharmatest Services. Models of hormonal action. Pharmatest is a CRO offering translational research services for diseases with unmet clinical needs. We offer full-service research solutions for early drug development. Our focus is on preclinical efficacy models in the fields of cancer. We place special emphasis on the high clinical predictivity and quality of the data acquired. All research models that...
pharmatest.com
List of publications - Pharmatest Services
http://www.pharmatest.com/references1/list-publications
Clinically predictive preclinical efficacy testing services at your disposal". Jussi Halleen - CEO, Pharmatest Services. LIST OF PUBLICATIONS BY PHARMATEST (June 30, 2015). PUBLISHED SCIENTIFIC PAPERS INCLUDING RESULTS FROM STUDIES PERFORMED IN PHARMATEST. Konkol Y, Bernoulli J. Streng T, Jääskeläinen K, Laihia J, Leino L 2015 Intravesical treatment with cis-urocanic acid improves bladder function in rat model of acute bladder inflammation. Neurourol Urodyn doi: 10.1002/nau.22818. Bernoulli J, Konkol Y.
pharmatest.com
Skeletal disease models - Pharmatest Services
http://www.pharmatest.com/services/skeletal-disease-models
Clinically predictive preclinical efficacy testing services at your disposal". Jussi Halleen - CEO, Pharmatest Services. In vitro assays, osteoclasts. In vitro assays, osteoblasts. Models of hormonal action. Pharmatest offers full-service efficacy testing of new drug candidates for treatment of osteoporosis and osteoarthritis. Our osteoporosis models include. Our ovariectomy (OVX) and orchidectomy (ORX) models are ideal choices for the efficacy testing of anti-catabolic and anabolic compounds for postmen...
pharmatest.com
Pharmatest Services Ltd participates Tumor Models event in Boston - Pharmatest Services
http://www.pharmatest.com/index.php/news/pharmatest-services-ltd-participates-tumor-models-event-bost
Clinically predictive preclinical efficacy testing services at your disposal". Jussi Halleen - CEO, Pharmatest Services. Pharmatest Services Ltd participates Tumor Models event in Boston. Pharmatest Services Ltd attends Tumor Models event of Hanson Wade held in Boston, MA, USA, on July 21 23. Pharmatest has a sponsored talk and three poster presentations in the event, and welcomes everyone to visit our booth. Pharmatest attends Tumor models event with the following scientific presentations:. Poster prese...
pharmatest.com
REFERENCES - Pharmatest Services
http://www.pharmatest.com/references1
Clinically predictive preclinical efficacy testing services at your disposal". Jussi Halleen - CEO, Pharmatest Services. Pharmatest has provided assistance for almost a hundred pharmaceutical, biotechnology and nutraceutical companies worldwide in their efficacy research. Most of our customers come to us before their candidates enter official pipelines and therefore wish to remain undisclosed. Therefore, we do not disclose any of our customers unless they specifically agree. July 15, 2016. Pharmatest is ...
pharmatest.com
Pharmatest to attend 2015 OARSI World Congress in Seattle - Pharmatest Services
http://www.pharmatest.com/index.php/news/pharmatest-attend-2015-oarsi-world-congress-seattle
Clinically predictive preclinical efficacy testing services at your disposal". Jussi Halleen - CEO, Pharmatest Services. Pharmatest to attend 2015 OARSI World Congress in Seattle. Pharmatest will be attending the 2015 Osteoarthritis Research Society International (OARSI) World Congress in Seattle, WA, USA on April 30 - May 3, 2015. If you would like to meet our representative during the meeting, please click here. July 15, 2016. Pharmatest started its current US sales strategy by opening its first US sal...
pharmatest.com
Efficacy testing of new cancer drug candidates
http://www.pharmatest.com/services/cancer-models
Clinically predictive preclinical efficacy testing services at your disposal". Jussi Halleen - CEO, Pharmatest Services. Models of hormonal action. Pharmatest offers full-service efficacy testing of new cancer drug candidates. Pharmatest’s strategy is to offer. Cancer cell cultures and clinically predictive animal models with the same cancer cell lines. The. Studies will demonstrate what cancer cell lines are affected by the test compounds, and the efficacy is then confirmed. Pharmatest is specialized in...
pharmatest.com
Pharmatest Services Ltd participates CIBD in Rotterdam - Pharmatest Services
http://www.pharmatest.com/index.php/news/pharmatest-services-ltd-participates-cibd-rotterdam
Clinically predictive preclinical efficacy testing services at your disposal". Jussi Halleen - CEO, Pharmatest Services. Pharmatest Services Ltd participates CIBD in Rotterdam. Pharmatest Services Ltd attends Cancer-Induced Bone Disease (CIBD) meeting held in parallel with the ECTS-IBMS meeting in Rotterdam, The Netherlands, on April 25 28. Pharmatest has three scientific presentations in the event. Pharmatest attends CIBD meeting with the following three scientific presentations:. Radium-223 dichloride ...
SOCIAL ENGAGEMENT